(Q42959127)

11 November 2017

0 references

Subcutaneous injection versus subcutaneous infusion of insulin: are the rates of absorption truly the same? (English)

1 reference

11 November 2017

1 reference

1

Lutz Heinemann

1 reference

11 November 2017

Solomon Steiner

2

1 reference

11 November 2017

1 September 2011

1 reference

Journal of Diabetes Science and Technology

11 November 2017

1 reference

11 November 2017

5

1 reference

11 November 2017

5

1 reference

11 November 2017

1027-1029

1 reference

Reduction of postprandial glycemic excursions in patients with type 1 diabetes: a novel human insulin formulation versus a rapid-acting insulin analog and regular human insulin

11 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208856

Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208856

Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208856

Insulin absorption from lipodystrophic areas: a (neglected) source of trouble for insulin therapy?

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208856

Insulin pump therapy: what is the evidence for using different types of boluses for coverage of prandial insulin requirements?

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208856

Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208856

A novel insulin formulation with a more rapid onset of action.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208856

Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208856

The Pharmacokinetics of Insulin After Continuous Subcutaneous Infusion or Bolus Subcutaneous Injection in Diabetic Patients

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208856

Insulin pharmacokinetics following continuous infusion and bolus injection of regular porcine and human insulin in healthy man

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22027293

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22027293

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1177/193229681100500501

1 reference

11 November 2017

1 reference

11 November 2017

1 reference

PMCID

3208856